1: (ROOT (S (S (NP (JJ New) (NNS Data)) (VP (VP (VBP Suggest) (NP (CD COVI-19)) (VP (MD May) (RB Not) (VP (VB Be) (ADJP (ADJP (RB As) (JJ Deadly)) (PP (IN As) (PP (IN ThoughtWith) (S (NP (JJR more) (NN antibody) (NN testing)) (VP (VBG being) (VP (VBN done)))))))))) (NP (DT a) (JJ recent) (NN study)) (VP (VBZ has) (VP (VP (VBN found) (SBAR (IN that) (S (NP (EX there)) (VP (MD may) (VP (VB be) (NP (NP (QP (QP (RB as) (JJ many) (IN as) (CD 5) (CD -)) (NN 85)) (NN %)) (PP (IN as) (NP (NP (JJ many) (NNS infections)) (SBAR (IN as) (S (NP (EX there)) (VP (VBP are) (NP (VBN known) (NNS cases))))))))))))) (, ,) (PP (VBN based) (PP (IN on) (NP (PRP$ their) (NNS findings)))))))) (, ,) (NP (DT this)) (VP (VBZ suggests) (SBAR (IN that) (S (S (NP (EX there)) (VP (MD could) (ADVP (RB actually)) (VP (VB be) (NP (DT a) (JJR lower) (NN fatality) (NN rate))))) (CC and) (S (NP (CD COVI-19)) (VP (MD may) (RB not) (VP (VB be) (ADJP (ADJP (RB as) (JJ deadly)) (SBAR (IN as) (S (NP (PRP we)) (ADVP (RB once)) (VP (VBD thought))))))))))) (. .)))
2: (ROOT (S (NP (DT This)) (VP (VBZ is) (RB not) (S (VP (TO to) (VP (VB say) (SBAR (IN that) (S (NP (PRP it)) (VP (VBZ is) (RB not) (NP (NP (NP (NN something)) (SBAR (S (VP (TO to) (VP (VB be) (ADJP (VBN concerned) (PP (IN about)))))))) (, ,) (PP (ADVP (RB especially)) (IN for) (NP (NP (DT those)) (PP (IN with) (NP (ADJP (RB pr) (HYPH -) (VBG existing)) (NNS conditions))))) (, ,)) (SBAR (ADVP (RB just)) (IN that) (S (NP (DT the) (NN fatality) (NNS rates)) (VP (MD may) (VP (VB be) (ADJP (JJR lower))))))))))))) (. .)))
3: (ROOT (S (NP (NP (DT The) (NML (VBN shut) (RP down)) (CC and) (NML (NN lock) (NNS downs))) (PP (IN of) (NP (JJ recent) (NNS months)))) (VP (VBP have) (DT all) (VP (VBN been) (VP (VBN based) (PP (IN on) (NP (DT the) (NN premise) (SBAR (IN that) (S (NP (CD COVI-19)) (VP (MD would) (VP (VB kill) (NP (QP (JJR more) (IN than) (CD 2) (CD million)) (NNS Americans)) (PP (IN without) (S (VP (VBG taking) (NP (DT some) (JJ serious) (NNS actions) (S (VP (TO to) (VP (VB slow) (PRT (RP down)) (NP (NP (DT the) (NN spread)) (PP (IN of) (NP (DT the) (NN virus))))))))))) (, ,) (SBAR (IN as) (S (NP (PRP we)) (VP (VBD did) (`` ') (RB t) (VP (VB have) (NP (NP (DT any) (NN immunity)) (PP (IN to) (NP (DT this) (JJ novel) (NN disease))))))))))))))))) (. .)))
4: (ROOT (S (S (NP (NP (DT The) (NN model)) (VP (VBN used) (PP (IN at) (NP (DT that) (NN time))))) (VP (VBD assumed) (S (NP (DT the) (NML (NN case) (NN fatality)) (NNS rates)) (VP (VBG being) (PP (IN at) (NP (CD -3) (NN %))))))) (, ,) (CC and) (S (PP (IN at) (NP (DT the) (NN time))) (NP (-LRB- ..) (NNP O)) (VP (VBD estimated) (NP (NP (DT a) (NML (NN case) (NN fatality)) (NN rate)) (PP (IN of) (NP (CD .4) (NN %)))))) (. .)))
5: (ROOT (S (NP (DT Some) (NNS experts)) (VP (VBP are) (VP (VBG questioning) (NP (DT these) (NNS assumptions)) (, ,) (S (VP (VBG arguing) (SBAR (IN that) (S (PP (IN without) (NP (JJ widespread) (JJ accurate) (NN testing))) (NP (DT the) (JJ known) (NNS cases)) (VP (VP (VBP are) (ADJP (JJ likely) (S (VP (TO to) (VP (VB be) (NP (NP (RB only) (DT a) (ADJP (RB very) (JJ small)) (NN portion)) (PP (IN of) (NP (NP (DT the) (JJ true) (NN number)) (PP (IN of) (NP (NNS infections)))))) (PP (VBN given) (NP (NP (DT the) (NN ease)) (PP (IN of) (NP (NN spread)))))))))) (, ,) (CC and) (S (ADVP (RB thus)) (S (NP (JJ high) (NML (NN case) (NN fatality)) (NN rate)) (VP (MD could) (VP (VB be) (PP (ADVP (RB well)) (IN off) (NP (DT the) (NN mark))) (PP (IN by) (NP (NP (NNS orders)) (PP (IN of) (NP (NN magnitude)))))))))))))))) (. .)))
6: (ROOT (S (NP (DT The) (NN truth)) (VP (VBZ is) (SBAR (IN that) (S (NP (PRP we)) (VP (VBP do) (`` ') (RB t) (VP (VB know) (SBAR (WHNP (WHNP (WDT what) (NN portion)) (PP (IN of) (NP (NNS infections)))) (S (VP (VBP have) (VP (VP (VBN gone) (ADJP (VBN undetected))) (CC and) (ADVP (ADVP (RB probably)) (ADVP (IN since))) (VP (VBN cleared) (PP (IN in) (NP (NP (DT the) (JJ vast) (NN majority)) (PP (IN of) (NP (DT the) (NN population)))))) (PP (IN due) (IN to) (NP (NP (NP (NN lack)) (PP (IN of) (NP (NN testing)))) (, ,) (NP (NP (DT the) (ADJP (RB highly) (JJ restrictive)) (NNS qualifications)) (SBAR (S (VP (TO to) (VP (VB get) (VP (VBN tested))))))) (, ,) (CC and) (NP (NP (DT the) (ADJP (RB potentially) (JJ large)) (NN incidence)) (PP (IN of) (NP (NP (NP (JJ mild) (NN illness)) (CC or) (NP (JJ asymptomatic) (NN infection))) (PP (IN to) (NP (NP (DT this) (ADJP (RB highly) (JJ contagious)) (NN virus)) (VP (VBG running) (ADVP (RB amok)) (PP (IN since) (NP (NNP January))) (PP (IN at) (NP (DT an) (JJ unknown) (NN rate)))))))))))))))))))) (. .)))
7: (ROOT (S (SBAR (IN As) (S (NP (DT the) (NNS weeks)) (VP (VBP pass)))) (NP (JJR more) (NNS data)) (VP (VBZ is) (VP (VBG being) (VP (VBN released) (S (VP (S (VP (VBG supporting) (NP (DT these) (NNS views)))) (PP (JJ such) (IN as) (NP (NP (NP (DT a) (JJ recent) (JJ preliminary) (NN study)) (PP (IN from) (NP (NP (NNS researchers)) (PP (IN at) (NP (NNP Stanford)))))) (SBAR (WHNP (WDT which)) (S (VP (VBD conducted) (NP (DT a) (NN seroprevalence) (NN study)) (PP (IN of) (NP (NP (NML (NNP Santa) (NNP Clara)) (NNP County)) (, ,) (NP (NNP California)))) (PP (IN on) (NP (NNP April) (CD -4) (, ,) (CD 2020))) (S (VP (VBG studying) (NP (NP (DT a) (JJ representative) (NN sampling)) (PP (IN of) (NP (QP (CD ,) (CD 300)) (NNS residents)))) (S (VP (TO to) (VP (VB test) (PP (PP (IN for) (NP (DT the) (NN presence)) (PP (IN of) (NP (NNS antibodies)))) (PP (IN in) (NP (PRP$ their) (NN blood)))) (S (VP (TO to) (VP (VB show) (SBAR (IN if) (S (NP (PRP they)) (VP (VBD had) (ADVP (RB previously)) (VP (VBN been) (VP (VBN infected) (PP (IN with) (NP (CD COVI-19)))))))))))))))))))))))))) (. .)))
8: (ROOT (S (NP (DT This) (NN study)) (VP (VBD revealed) (SBAR (IN that) (S (NP (NP (DT the) (NML (NNP Bay) (NNP Area)) (NNS infections)) (PP (VBN based) (PP (IN on) (NP (DT the) (NN antibody) (NN testing))))) (VP (VBD were) (ADJP (ADJP (ADJP (QP (CD 85) (NNS times)) (JJR higher)) (PP (IN than) (SBAR (WHNP (WP what)) (S (VP (VBD had) (VP (VBN been) (VP (VBN reported)))))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (PP (ADVP (RB largely)) (IN due) (IN to) (NP (NP (NP (DT the) (NN lack)) (PP (IN of) (NP (NN testing)))) (CC and) (NP (NP (JJ asymptomatic) (NNS carriers)) (VP (VBG allowing) (S (NP (DT the) (NN virus)) (VP (TO to) (VP (VB spread) (ADJP (JJ unknown))))))))))))))))) (. .)))
9: (ROOT (S (S (NP (DT The) (NNS researchers)) (VP (VBP suggest) (SBAR (IN that) (S (NP (PRP$ their) (NNS data)) (VP (MD may) (VP (VB help) (S (VP (TO to) (ADVP (RBR better)) (VP (VB estimate) (NP (NP (DT the) (JJ true) (NN fatality) (NN rate)) (PP (IN of) (NP (DT this) (NN virus))))))))))))) (: ;) (S (NP (NP (DT the) (NN population) (NN prevalence)) (PP (IN of) (NP (HYPH COVI-19))) (PP (IN in) (NP (NNP Santa) (NNP Clara))) (PP (IN among) (NP (DT the) (QP (CD ,) (CD 300)) (NNS adults) (CC and) (NNS children)))) (VP (VBD ranged) (PP (PP (IN from) (NP (CD .49) (NN %))) (PP (IN to) (NP (CD .16) (NN %)))))) (. .)))
10: (ROOT (S ('' `) (NP (NP (DT The) (ADJP (RBS most) (JJ important)) (NN implication)) (PP (IN of) (NP (DT these) (NNS findings)))) (VP (VP (VBZ is) (SBAR (IN that) (S (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NNS infections)))) (VP (VBZ is) (ADJP (ADJP (RB much) (JJR greater)) (PP (IN than) (NP (NP (DT the) (VBN reported) (NN number)) (PP (IN of) (NP (NNS cases)))))))))) (, ,) ('' ') (NP (DT the) (NNS researchers)) (VP (VBD wrote) (, ,) (PP (IN in) (NP (DT a) (ADJP (PRP ye) (HYPH -) (RB t) (HYPH -) (VP (VB be) (ADJP (NN pee) (HYPH -) (VBN reviewed)))) (NN study))))) (. .)))
11: (ROOT (S (NP (PRP$ Our) (NNS data)) (VP (VBP imply) (SBAR (IN that) (, ,) (S (PP (IN by) (NP (NNP April) (CD 1))) (NP (QP (IN between) (CD 4,000) (CC and) (CD 8,000)) (NNS people)) (VP (VBD had) (VP (VBN been) (VP (VBN infected) (PP (IN in) (NP (NML (NNP Santa) (NNP Clara)) (NNP County))))))))) (. .)))
12: (ROOT (S (NP (NP (DT The) (VBN reported) (NN number)) (PP (PP (IN of) (NP (VBN confirmed) (JJ positive) (NNS cases))) (PP (IN in) (NP (DT the) (NN county)))) (PP (IN on) (NP (NNP April) (CD 1)))) (VP (VBD was) (ADJP (ADJP (NP (CD 956) (, ,) (NP (CD 5) (CD -) (CD 8) (HYPH -) (RB fold))) (JJR lower)) (PP (IN than) (NP (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NNS infections)))) (VP (VBN predicted) (PP (IN by) (NP (DT this) (NN study)))))))) (. .) ('' ')))
13: (ROOT (S (`` `) (S (NP (NP (JJ Many) (NNS estimates)) (PP (IN of) (NP (NN fatality) (NN rate)))) (VP (VBP use) (NP (NP (NP (DT a) (NN ratio)) (PP (PP (IN of) (NP (NNS deaths))) (PP (IN to) (NP (JJ lagged) (NNS cases))))) (, ,) (PP (IN with) (NP (NP (DT an) (NML (NN infection) (HYPH -) (NN t) (HYPH -) (NNS cases)) (NN ratio)) (PP (IN in) (NP (DT the) (NML (CD -5) (NN fold)) (NN range)))))) (PP (IN as) (NP (NP (DT an) (NN estimate)) (PP (IN of) (NP (FW unde) (HYPH -) (NN ascertainment))))))) (, ,) ('' ') (NP (DT the) (NNS researchers)) (VP (VBD wrote)) (. .)))
14: (ROOT (S (NP (PRP$ Our) (NN study)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NP (NNS adjustments)) (PP (IN for) (NP (NN unde) (HYPH -) (NN ascertainment)))) (VP (MD may) (VP (VB need) (S (VP (TO to) (VP (VB be) (ADJP (RB much) (JJR higher)))))))))) (. .) ('' ')))
15: (ROOT (S (S (VP (VBG Detecting) (NP (NP (ADJP (RB previously) (JJ unreported)) (NNS cases)) (PP (IN of) (NP (CD COVI-19) (NNS infections)))))) (VP (MD could) (VP (VB lead) (PP (IN to) (NP (NP (DT a) (JJR better) (NN estimation)) (PP (IN of) (NP (DT the) (NN fatality) (NN rate))))))) (. .)))
16: (ROOT (S (S (NP (DT This) (NN study)) (VP (VBD was) (RB not) (PP (IN without) (NP (NNS limitations))))) (, ,) (CC but) (S (SBAR (IN after) (S (NP (NNS adjustments)) (VP (VBD were) (VP (VBN made) (S (VP (TO to) (VP (VB take) (NP (DT these)) (PP (IN into) (NP (NN account)))))))))) (NP (DT the) (NNS researchers)) (VP (VBP suggest) (SBAR (S (NP (DT these) (NNS results)) (VP (MD could) (VP (VB be) (VP (VBN applied) (PP (IN to) (NP (JJ other) (NNS areas)))))))))) (. .)))
17: (ROOT (S (`` `) (S (SBAR (IN While) (S (NP (PRP$ our) (NN study)) (VP (VBD was) (VP (VBN limited) (PP (IN to) (NP (NML (NNP Santa) (NNP Clara)) (NNP County))))))) (, ,) (NP (PRP it)) (VP (VP (VBZ demonstrates) (NP (NP (DT the) (NN feasibility)) (IN of) (NP (NN seroprevalence) (NNS surveys))) (PP (IN of) (NP (NN population) (NNS samples))) (ADVP (RB now))) (, ,) (CC and) (PP (IN in) (NP (DT the) (NN future))) (, ,) (S (VP (TO to) (VP (VP (VB inform) (NP (NP (PRP$ our) (NN understanding)) (PP (IN of) (NP (NP (DT this) (NN pandemic) (POS 's)) (NN progression))))) (, ,) (VP (VB project) (NP (NP (NNS estimates)) (PP (IN of) (NP (NN community) (NN vulnerability))))) (, ,) (CC and) (VP (VB monitor) (NP (NP (NML (NN infection) (NN fatality)) (NNS rates)) (PP (IN in) (NP (JJ different) (NNS populations)))) (PP (IN over) (NP (NN time))))))))) (, ,) ('' ') (NP (DT the) (NNS researchers)) (VP (VBD said)) (. .)))
18: (ROOT (S (NP (PRP It)) (VP (VBZ is) (ADVP (RB also)) (NP (NP (DT an) (JJ important) (NN tool)) (PP (IN for) (S (VP (VBG reducing) (NP (NP (NN uncertainty)) (PP (IN about) (NP (NP (NP (DT the) (NN state)) (PP (IN of) (NP (DT the) (NN epidemic)))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB have) (NP (JJ important) (JJ public) (NNS benefits)))))))))))))) (. .) ('' ')))
19: (ROOT (SINV (`` `) (S (NP (DT This)) (ADVP (RB probably)) (VP (VBZ aligns) (PP (PP (IN with) (SBAR (WHNP (WP what)) (S (NP (JJ overall) (JJ national) (NN exposure)) (VP (MD may) (VP (VB be)))))) (, ,) (PP (IN on) (NP (NP (NN order)) (PP (IN of) (NP (QP (RB about) (CD 5)) (NN percent)))))) (SBAR (IN once) (S (NP (PRP we)) (VP (VBP do) (NP (JJ wide) (NN serology))))))) (, ,) ('' ') (VP (VBD tweeted)) (NP (NP (NP (NNP D.) (NNP Scott) (NNP Gottlieb)) (, ,) (NP (JJ former) (NNP FDA) (NN commissioner))) (, ,) (S (VP (VBG agreeing) (SBAR (IN that) (S (NP (DT these) (NNS findings)) (ADVP (RB likely)) (VP (VBP align) (PP (IN with) (SBAR (WHNP (WP what)) (S (NP (DT the) (JJ overall) (JJ national) (NN exposure)) (VP (MD may) (VP (VB look) (PP (IN like))))))))))))) (. .)))
20: (ROOT (S (S (NP (NNP Santa) (NNP Clara)) (VP (VBD was) (NP (DT a) (JJ hot) (NN spot)))) (CC and) (S (NP (PRP I)) (VP (MD would) (VP (VB have) (VP (VBN expected) (S (NP (NN exposure)) (VP (TO to) (VP (VB be) (ADJP (JJR higher))))))))) (. .)))
21: (ROOT (S (ADVP (RB Overall)) (NP (PRP we)) (VP (VBP 're) (ADVP (RB probably)) (VP (VBG diagnosing) (NP (QP (CD 1) (IN in) (CD 10) (IN to) (CD 1) (IN in) (CD 20)) (NNS infections)))) (. .) ('' ')))
22: (ROOT (S (NP (NNP Gottlieb)) (ADVP (RB also)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NP (NP (JJ other) (JJ hot) (NNS zones)) (PP (JJ such) (IN as) (NP (NNP New) (NNP York)))) (SBAR (WHNP (WDT that)) (S (VP (VBP have) (VP (VBN reported) (NP (NP (QP (IN over) (CD 22,000)) (NNS cases)) (PP (IN of) (NP (NN infection))))))))) (VP (VBP have) (NP (NP (NNS data)) (`` `) (SBAR (S (VP (TO to) (VP (VB suggest) (SBAR (S (NP (DT the) (NN infection) (NN rate)) (VP (MD may) (VP (VB be) (ADJP (RB much) (JJR higher))))))))))))))) (. .) ('' ')))
23: (ROOT (S (`` `) (S (NP (PRP We)) (VP (VBP 're) (ADVP (RB also)) (ADJP (JJ likely) (S (VP (TO to) (VP (VB find) (NP (NP (JJR higher) (NNS rates)) (PP (IN of) (NP (NN infection))) (PP (IN among) (NP (JJ certain) (NNS jobs)))))))))) (, ,) ('' ') (NP (PRP he)) (VP (VBD tweeted)) (. .)))
24: (ROOT (S (CC But) (NP (DT the) (NNS data)) (ADVP (RB so) (RB far)) (VP (VBP suggest) (SBAR (IN that) (S (ADVP (RB nationally)) (, ,) (NP (JJ total) (NN exposure)) (VP (VBZ is) (ADVP (RB still)) (ADJP (JJ low)))))) (. .) ('' ')))
25: (ROOT (S (SBAR (IN As) (S (NP (JJ several) (NNS states)) (VP (VBP begin) (S (VP (TO to) (ADVP (RB cautiously)) (VP (VB reopen))))))) (NP (EX there)) (VP (VBZ has) (VP (VBN been) (NP (NP (DT an) (VBN increased) (NN push)) (PP (IN for) (NP (NP (NN antibody) (NN testing)) (SBAR (WHNP (WDT which)) (S (, ,) (SBAR (IN if) (FRAG (ADJP (JJ accurate)))) (, ,) (VP (MD may) (VP (VB be) (ADJP (JJ able) (S (VP (TO to) (VP (VB reveal) (SBAR (WHNP (SBAR (WHNP (WP who)) (S (ADVP (RB already)) (VP (VBD had) (NP (DT the) (NN virus))))) (WHNP (WP who))) (S (VP (MD may) (RB not) (VP (VB have) (VP (VBN been) (VP (VBN tested) (PP (IN for) (NP (PRP it)))))))))))))))))))))) (. .)))
26: (ROOT (S (NP (NN Antibody) (NN testing)) (VP (VP (MD can) (VP (VB be) (VP (VBN conducted) (PP (IN via) (NP (NN blood)))))) (CC but) (VP (MD can) (ADVP (RB also)) (VP (VB be) (VP (VBN done) (S (VP (VBG using) (NP (NP (NN saliva)) (VP (VBG looking) (S (VP (TO to) (VP (VB detect) (NP (NP (NML (NNP IgM) (CC and) (NNP IgG)) (NNS antibodies)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB take) (NP (QP (IN up) (IN to) (CD 14)) (NNS days)) (S (VP (TO to) (VP (VB develop)))))))))))))))))))) (. .)))
27: (ROOT (SINV ('' `) (S (S (NP (NP (DT Those)) (SBAR (WHNP (WP who)) (S (VP (VBP test) (ADVP (JJ positive)) (PP (IN for) (NP (NN immunity))))))) (, ,) (PP (IN in) (NP (NN theory))) (, ,) (VP (VBP are) (ADJP (JJ safe) (S (VP (TO to) (VP (VB return) (PP (IN to) (NP (NN work))))))))) (CC but) (S (NP (NP (PRP it))) (VP (VBZ is) (S (VP (S (VP (TO to) (VP (VB be) (RB very) (VBN cautioned) (PP (IN against) (S (VP (VBG doing) (ADVP (RB so)))))))) (VP (VBG considering) (SBAR (S (NP (JJ medical) (NNS professionals)) (VP (VBP are) (ADVP (RB still)) (VP (VBG learning) (PP (IN about) (NP (DT this) (NN virus))))))))))))) (, ,) ('' ') (VP (VBD said)) (NP (NNP D.) (NNP Robert) (NNP Segal)) (. .)))
28: (ROOT (S (S (NP (DT The) (JJ human) (NN race)) (VP (VBZ has) (RB not) (VP (VBN developed) (NP (NP (DT an) (NN immunity)) (PP (IN to) (NP (DT this) (NN virus))))))) (, ,) (S (NP (EX there)) (VP (VBZ is) (NP (DT a) (NN possibility) (SBAR (IN that) (S (NP (NN r) (HYPH -) (NNS infections)) (VP (MD could) (VP (VB occur)))))))) (. .)))
29: (ROOT (S (NP (PRP We)) (VP (MD can) (RB not) (VP (VB be) (ADJP (JJ certain) (PP (IN of) (NP (DT that)))) (PP (IN at) (NP (DT this) (NN time))))) (. .) ('' ')))
30: (ROOT (S (NP (NP (NN Accuracy)) (PP (IN of) (NP (NP (DT these)) (VP (VBN rushed) (PP (IN to) (NP (NN market) (NNS tests))))))) (VP (VBP have) (ADVP (RB however)) (VP (VBN been) (VP (VBN called) (PP (IN into) (NP (NN question)))))) (. .)))
31: (ROOT (S (S (PP (IN As) (PP (IN with) (NP (DT any) (NN test)))) (NP (NN accuracy)) (VP (VBZ is) (ADVP (RB always)) (NP (DT a) (NN concern)))) (, ,) (CC and) (S (NP (NP (JJ many)) (PP (IN of) (NP (DT these) (VBN rushed) (NN serology) (NNS tests)))) (VP (VBP have) (ADVP (RB yet)) (S (VP (TO to) (VP (VB be) (VP (VBN approved) (PP (IN by) (NP (DT the) (NNP FDA))))))))) (. .)))
32: (ROOT (S (S (NP (NP (NNP John) (NNP Brownstein)) (NP (NP (DT an) (NN epidemiologist)) (PP (IN at) (NP (NP (NNP Boston) (NNPS Children) (POS 's)) (NNP Hospital))))) (VP (VBD said) (SBAR (IN that) (S (NP (EX there)) (VP (VBZ is) (NP (NP (VBG growing) (NN recognition)) (PP (IN in) (NP (DT the) (NN field))) (SBAR (IN that) (S (NP (NP (DT the) (NNS numbers)) (PP (IN of) (NP (NP (DT those)) (VP (VBN infected))))) (VP (VBP are) (ADJP (ADJP (RB far) (JJR greater)) (PP (IN than) (NP (DT the) (JJ official) (NNS numbers))))))))))))) (, ,) (CC and) (S (ADVP (RB ultimately)) (NP (PRP he)) (VP (VBZ says) (PP (IN about) (NP (DT this) (NN study))) (SBAR (IN that) (, ,) (`` `) (S (NP (PRP It)) (VP (VBZ adds) (PP (IN to) (NP (NP (NP (VBG growing) (NN body)) (PP (IN of) (NP (NN work)))) (SBAR (WHNP (WDT that)) (S (VP (VBZ suggests) (NP (NP (DT a) (JJ huge) (NN amount)) (PP (IN of) (NP (NP (NNS cases)) (SBAR (WHNP (WDT that)) (S (VP (VBD went) (ADJP (VBN undetected)))))))))))))))))) (. .) ('' ')))
